Raymond James Financial Services Advisors Inc. raised its position in shares of Aetna Inc. (NYSE:AET) by 6.2% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 39,593 shares of the company’s stock after purchasing an additional 2,307 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Aetna were worth $6,011,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of AET. BlackRock Inc. grew its stake in Aetna by 3,374.9% during the 1st quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock valued at $3,917,344,000 after purchasing an additional 29,828,390 shares during the last quarter. FMR LLC lifted its holdings in shares of Aetna by 73.8% in the 2nd quarter. FMR LLC now owns 13,736,800 shares of the company’s stock valued at $2,085,659,000 after buying an additional 5,833,567 shares during the period. Janus Henderson Group PLC lifted its holdings in shares of Aetna by 9,446.2% in the 2nd quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock valued at $657,255,000 after buying an additional 4,283,553 shares during the period. Capital World Investors lifted its holdings in shares of Aetna by 8.9% in the 2nd quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock valued at $3,153,358,000 after buying an additional 1,688,767 shares during the period. Finally, Vanguard Group Inc. lifted its holdings in shares of Aetna by 3.8% in the 1st quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock valued at $2,948,640,000 after buying an additional 838,578 shares during the period. Institutional investors and hedge funds own 89.52% of the company’s stock.
WARNING: “Aetna Inc. (AET) Shares Bought by Raymond James Financial Services Advisors Inc.” was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://stocknewstimes.com/2017/10/12/aetna-inc-aet-shares-bought-by-raymond-james-financial-services-advisors-inc.html.
In other Aetna news, President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the sale, the president now directly owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Margaret M. Mccarthy sold 10,288 shares of Aetna stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the completion of the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,465,734.55. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by insiders.
Several equities analysts have recently issued reports on the company. Zacks Investment Research raised Aetna from a “hold” rating to a “buy” rating and set a $174.00 price objective for the company in a report on Thursday. Cantor Fitzgerald reissued an “overweight” rating and issued a $175.00 price objective (up previously from $150.00) on shares of Aetna in a report on Wednesday, August 9th. Jefferies Group LLC reissued a “hold” rating and issued a $163.00 price objective (up previously from $157.00) on shares of Aetna in a report on Friday, August 4th. Deutsche Bank AG boosted their price objective on Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a report on Monday, August 7th. Finally, Royal Bank Of Canada boosted their price objective on Aetna from $162.00 to $171.00 and gave the company an “outperform” rating in a report on Friday, August 4th. Seven investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $160.99.
Aetna (NYSE:AET) last released its earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.34 by $1.08. The firm had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. Aetna’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same period in the previous year, the company earned $2.21 EPS.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Thursday, October 12th will be paid a $0.50 dividend. The ex-dividend date is Wednesday, October 11th. This represents a $2.00 annualized dividend and a yield of 1.28%. Aetna’s payout ratio is currently 43.67%.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.